TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
TWD 9.92
(-2.27%)
TWD 9.92
(-2.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 74.68 Million TWD | 94.14% |
| 2022 | 38.47 Million TWD | -28.04% |
| 2021 | 53.45 Million TWD | 212.22% |
| 2020 | 17.12 Million TWD | -74.13% |
| 2019 | 66.19 Million TWD | 0.0% |
| 2018 | - TWD | 0.0% |
| 2017 | - TWD | 0.0% |
| 2016 | - TWD | 0.0% |
| 2015 | - TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| 2011 | - TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 66.74 Million TWD | -5.63% |
| 2024 Q1 | 70.72 Million TWD | -5.31% |
| 2023 Q3 | 78.62 Million TWD | -4.75% |
| 2023 Q4 | 74.68 Million TWD | -5.01% |
| 2023 FY | 74.68 Million TWD | 94.14% |
| 2023 Q1 | 30.91 Million TWD | -19.63% |
| 2023 Q2 | 82.54 Million TWD | 166.98% |
| 2022 Q1 | 48.99 Million TWD | -8.35% |
| 2022 FY | 38.47 Million TWD | -28.04% |
| 2022 Q4 | 38.47 Million TWD | -3.82% |
| 2022 Q2 | 50.5 Million TWD | 3.09% |
| 2022 Q3 | 40 Million TWD | -20.8% |
| 2021 Q3 | 3.13 Million TWD | -59.9% |
| 2021 Q4 | 53.45 Million TWD | 1604.11% |
| 2021 Q1 | 12.48 Million TWD | -27.08% |
| 2021 Q2 | 7.82 Million TWD | -37.34% |
| 2021 FY | 53.45 Million TWD | 212.22% |
| 2020 Q2 | 26.32 Million TWD | -14.79% |
| 2020 Q1 | 30.89 Million TWD | -53.33% |
| 2020 Q3 | 21.73 Million TWD | -17.43% |
| 2020 FY | 17.12 Million TWD | -74.13% |
| 2020 Q4 | 17.12 Million TWD | -21.23% |
| 2019 Q1 | 102.06 Million TWD | 0.0% |
| 2019 Q4 | 66.19 Million TWD | 59.57% |
| 2019 FY | 66.19 Million TWD | 0.0% |
| 2019 Q3 | 41.48 Million TWD | -57.14% |
| 2019 Q2 | 96.79 Million TWD | -5.17% |
| 2018 Q4 | - TWD | 0.0% |
| 2018 FY | - TWD | 0.0% |
| 2018 Q3 | - TWD | 0.0% |
| 2018 Q2 | - TWD | 0.0% |
| 2018 Q1 | - TWD | 0.0% |
| 2017 FY | - TWD | 0.0% |
| 2017 Q2 | - TWD | 0.0% |
| 2017 Q3 | - TWD | 0.0% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2016 FY | - TWD | 0.0% |
| 2016 Q4 | - TWD | 0.0% |
| 2016 Q3 | - TWD | 0.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2016 Q1 | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 FY | - TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q2 | - TWD | 0.0% |
| 2013 Q3 | - TWD | 0.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 81.456% |
| Level Biotechnology Inc. | 13.5 Million TWD | -453.155% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 90.053% |
| GlycoNex Incorporation | 900 Thousand TWD | -8198.556% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 70.943% |
| OBI Pharma, Inc. | 501.05 Million TWD | 85.094% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 76.67% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 73.666% |
| Visgeneer Inc. | 158.6 Million TWD | 52.91% |
| Neith Corporation | 3.54 Million TWD | -2009.206% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -492.284% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 96.217% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -6278.053% |
| Enimmune corporation | 45.73 Million TWD | -63.307% |
| TaiRx, Inc. | 12.28 Million TWD | -507.903% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -28.315% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 80.919% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -1166.311% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -591.674% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 9.531% |
| RBC Bioscience Corporation | 487.36 Million TWD | 84.675% |
| NaviFUS Corp. | 32.69 Million TWD | -128.45% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -1979.259% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -13782.342% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -419.562% |
| Sagittarius Life Science Corp | 13.32 Million TWD | -460.587% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 34.166% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -8484.713% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -470.478% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -1275.198% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -175.384% |
| Lin BioScience, Inc. | 42.87 Million TWD | -74.205% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -5300.362% |
| AP Biosciences Inc | 82.07 Million TWD | 9.006% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 57.098% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 89.045% |
| EirGenix Inc. | 465.16 Million TWD | 83.944% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 48.267% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 89.716% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -3432.971% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -1615.365% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 22.916% |
| VBI | - TWD | -Infinity% |
| BiOptic Inc. | 93.19 Million TWD | 19.862% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 82.09% |
| Sinew Pharma Inc. | 6.46 Million TWD | -1055.43% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 61.92% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 97.435% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -619.597% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 94.796% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 81.232% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -836.984% |
| TCI GENE Inc. | 6.79 Million TWD | -999.146% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -797.896% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -677.909% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 72.196% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -599.186% |
| PharmaEngine, Inc. | 14.8 Million TWD | -404.335% |
| Savior Lifetec Corporation | 270.37 Million TWD | 72.377% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | -119.416% |
| Acepodia, Inc. | 273.81 Million TWD | 72.723% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -265.075% |